Dr. Kevin Pfleger Discusses Novel nanoBRET Assay Development for High Throughput Screening

6 November 2017

Dr. Kevin Pfleger, Associate Professor at the University of Western Australia and Head of Molecular Endocrinology and Pharmacology at Harry Perkins Institute of Medical Research, discusses a recently published, novel nanoBRET assay that was developed in collaboration with BMG Labtech and Promega.